Form 4: Dynatrace Director Stephen Lifshatz Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Stephen Lifshatz sold 2,500 shares of Dynatrace, Inc. (DT) common stock at an average price of $60.8827 on February 10, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • On February 10, 2025, Stephen J Lifshatz, a director of Dynatrace, Inc., sold 2,500 shares of common stock.
  • The sale was executed at a weighted average price of $60.8827 per share, with individual prices ranging from $60.37 to $61.08.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 1, 2024.
  • Following the transaction, Lifshatz directly owns 36,471 shares of Dynatrace common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Sales by company directors are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on inside information.

Stakeholder Impact

  • The sale of shares by a director could have a minor negative impact on shareholder confidence, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
2024-03-01Date of adoption of Rule 10b5-1 trading plan
2025-02-10Date of transaction (sale of shares)
2025-02-11Date of signature

Keywords

Dynatrace, Lifshatz, Director, Share Sale, Form 4, 10b5-1 Trading Plan, DT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.